SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-14-016148
Filing Date
2014-03-05
Accepted
2014-03-05 07:12:12
Documents
4
Period of Report
2014-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-7398_18k.htm 8-K 26410
2 EX-99.1 a14-7398_1ex99d1.htm EX-99.1 78486
3 GRAPHIC g73981mmi001.gif GRAPHIC 3691
4 GRAPHIC g73981mmi002.jpg GRAPHIC 1547
  Complete submission text file 0001104659-14-016148.txt   113487
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 14667377
SIC: 2834 Pharmaceutical Preparations